PMID: 7028244Nov 15, 1981Paper

Follicular (nodular) lymphoma during the first two decades of life: a clinicopathologic study of 12 patients

Cancer
C D WinbergH Rappaport

Abstract

Twelve patients who developed non-Hodgkin's lymphoma with a follicular pattern during the first two decades of life were studied. Eight had the poorly differentiated lymphocytic type; the remaining four had the "histiocytic" type. Eleven of the 12 patients were male. Nine were asymptomatic, and eight had lymphadenopathy in the head and neck region. Comparison of ages revealed the extent of disease tended to be localized (Stages I and II) in the pediatric (less than 16 years old) patients (83%) and generalized in the adolescent-young adult (16-19 years old) patients (83%). Of ten patients treated with chemotherapy and/or radiotherapy, eight achieved complete remissions that lasted 3-58 months (median, 17.5 months). Five are still in remission; three have relapsed. Seven are alive 12-120 months from diagnosis (median, 48 months); six have no clinical evidence of disease. The remaining five patients died two to 164 months after diagnosis (median, 13 months). Three of the four patients who died with lymphoma had diffuse "histiocytic" lymphoma demonstrated at autopsy examination. Poor prognostic factors included 1) failure to achieve a complete remission following initial therapy; 2) extranodal disease (with the exception of the poo...Continue Reading

References

Sep 23, 1976·The New England Journal of Medicine·R B MannC W Berard
Nov 17, 1977·The New England Journal of Medicine·D T PurtiloW Edwards
Dec 28, 1978·The New England Journal of Medicine·S B Murphy
Jan 1, 1979·Annals of Internal Medicine·C S Portlock, S A Rosenberg
Aug 1, 1976·Cancer·B N NathwaniH Rappaport
Dec 1, 1975·Cancer·S B MurphyA E Evans
Dec 1, 1975·The Journal of Pediatrics·D TraggisA Baez-Giangreco
Apr 1, 1976·Cancer·R QaziJ C Long
Jul 1, 1974·Cancer·E GlatsteinH S Kaplan
Oct 1, 1974·Cancer·A S PatchefskyW S Hoch
Apr 1, 1972·Cancer·S E JonesH S Kaplan
Nov 1, 1966·Oral Surgery, Oral Medicine, and Oral Pathology·R L Sachs
Jan 1, 1946·American Journal of Clinical Pathology·S E COHEN, V W BERGSTROM

❮ Previous
Next ❯

Citations

Apr 8, 1999·Cancer·L S FinnK E Salhany
May 22, 2010·Current Hematologic Malignancy Reports·Bhuvana A Setty, Amanda M Termuhlen
Jul 15, 1998·International Journal of Pediatric Otorhinolaryngology·S DubeyJ T Morewaya
Oct 27, 2010·International Journal of Pediatrics·Vlasta FesslovaLaura Villa
Apr 15, 2004·American Journal of Clinical Pathology·Steven J KussickBrent L Wood
Jun 11, 2011·Best Practice & Research. Clinical Haematology·Itziar Salaverria, Reiner Siebert
Sep 30, 2015·Virchows Archiv : an International Journal of Pathology·Leticia Quintanilla-MartinezSteven H Swerdlow
Mar 1, 1987·Baillière's Clinical Haematology·C J Gallagher, T A Lister
Apr 5, 2011·Pediatric Blood & Cancer·Riten KumarShakila P Khan
Jul 1, 1992·Critical Reviews in Oncology/hematology·L WhiteT C Quah
Aug 31, 2011·Pediatric Hematology and Oncology·Sheau-Fang YangShih-Sung Chuang
Feb 24, 2015·Human Pathology·Tejashree KarnikRobert S Ohgami
Oct 29, 1998·British Journal of Haematology·A AtraC R Pinkerton
Mar 1, 1995·Cancer·C L MoertelS C Simonton
Oct 1, 1988·Cancer·R E HutchisonC W Berard
Mar 6, 2002·Blood·Robert B LorsbachFrederick G Behm
Jul 13, 2000·Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society·S L Perkins
Mar 22, 2001·Archives of Pathology & Laboratory Medicine·D LuL V Abruzzo
Jan 7, 2009·Archives of Pathology & Laboratory Medicine·Renuka Agrawal, Jun Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.